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Abstract
Objectives To investigate which anthropometric adiposity
measure has the strongest association with cardiovascular
disease (CVD) risk factors in Caucasian men and women
without a history of CVD.
Design Systematic review and meta-analysis.
Methods We searched databases for studies reporting correla-
tions between anthropometric adiposity measures and CVD
risk factors in Caucasian subjects without a history of CVD.
Body mass index (BMI), waist circumference, waist-to-hip
ratio, waist-to-height ratio and body fat percentage were con-
sidered the anthropometric adiposity measures. Primary CVD
risk factors were: systolic blood pressure, diastolic blood pres-
sure, high density lipoprotein (HDL) cholesterol, triglycerides
and fasting glucose. Two independent reviewers performed
abstract, full text and data selection.
Results Twentyarticleswereincludeddescribing21,618males
and 24,139 females. Waist circumference had the strongest
correlation with all CVD risk factors for both men and women,
except for HDL and LDL in men. When comparing BMI with
waist circumference, the latter showed significantly better cor-
relations to CVD risk factors, except for diastolic blood pres-
s u r ei nw o m e na n dH D La n dt o t a lc h o l e s t e r o li nm e n .
Conclusions We recommend the use of waist circumference
in clinical and research studies above other anthropometric
adiposity measures, especially compared with BMI, when
evaluating CVD risk factors.
Keywords Meta-analysis.Cardiovasculardiseaserisk
factors.Anthropometric.Adiposity.Waistcircumference
Introduction
The World Health Organisation reported cardiovascular dis-
ease (CVD) to be death cause number one globally with
29% of all-cause deaths, which is 17.1 million people, in
2004 [1]. Researchers found these mortality rates to be
closely associated to certain CVD risk factors [2–4]. These
CVD risk factors are abdominal obesity, high blood pres-
sure, low high-density lipoprotein cholesterol (HDL-C)
levels, high triglyceride levels and high fasting glucose
[2]. The criteria of the Adult Treatment Panel III (ATP III)
of the National Cholesterol Education Program state that
having three out of these five CVD risk factors defines the
metabolic syndrome and involves an overall increase in
all-cause and CVD death [2–4].
Adiposity has proven to be an important risk factor for
cardiovascular disease and is strongly associated with CVD
S. B. van Dijk (*)
School of Clinical Health Sciences, Department of Physical
Therapy Science, Utrecht University,
Utrecht, the Netherlands
e-mail: s.b.vandijk@kpnmail.nl
T. Takken
Child Development & Exercise Centre, Wilhelmina Children’s
Hospital, University Medical Centre Utrecht,
Lundlaan 6, Room KB2.056.0, PO Box 85090, 3508 AB Utrecht,
the Netherlands
E. C. Prinsen
Roessingh Research and Development,
Roessinghsbleekweg 33b, Room 16, PO Box 310, 7500 AH
Enschede, the Netherlands
H. Wittink
Research group Lifestyle and Health,
Research Centre for Innovation in Health Care,
University of Applied Sciences Utrecht,
Bolognalaan 101, Room 0.075, PO Box 85182, 3508 AD Utrecht,
the Netherlands
Neth Heart J (2012) 20:208–218
DOI 10.1007/s12471-011-0237-7risk factors [2, 5]. Most studies use anthropometric measures
to measure adiposity. Waist circumference and waist-to-hip
ratio have been used as measures of central obesity (where
visceral adipose tissue is stored), and body mass index (BMI)
(kg/m
2) has been used as a measure of general obesity [6].
Studies that analysed associations between anthropometric
measures and abdominalvisceralfat, measured with computed
tomography, reported waist circumference to be a better mea-
sure of central obesity [6–9].
A recent systematic review investigated the importance of
obesity and cardiorespiratory fitness related to the risks of and
mortality due to CVD and diabetes type 2 [5]. They found
BMI to be the most frequently used measure of adiposity in
theincludedstudiesandraiseafewquestionsabouttheoverall
applicability of the BMI. For instance, BMI neither gives an
indication of the relation between fat and fat-free mass, nor
doesitindicatefatdistribution.ForagivenBMI,physicallyfit
individuals have less total and abdominal fat, compared with
unfit individuals. A large muscle mass instead offat mass will
also place people in higher BMI categories. This is supported
by a large study that investigated the diagnostic accuracy of
BMI to detect adiposity [10]. They found limited diagnostic
performanceoftheBMIincorrectlyidentifyingindividualswith
excess in body fat (BF), particularly in those with BMI<30.
Although BMI has a good correlation with BF%, it failed to
discriminatebetweenBF%andleanmass[10].Inaddition,BMI
is also criticised because it makes no difference between men
and women, even though we know fat distribution is signifi-
cantly different between men and women [10,11]. Also age and
ethnicity have an effect on body fat distribution and are not
differentiated in BMI [7,11,12]. Is it not wiser to use a different
type of adiposity measurement?
Although relationships between anthropometric adiposity
measures and CVD risk factors have been explored thor-
oughly in many studies around the world, results have to our
knowledge never been combined quantitatively in a meta-
analysis. To eliminate ethnic differences we choose to focus
on studies that describe Caucasian populations.
Therefore the aim of this study was to study the following
research question: which anthropometric adiposity measure
has the strongest association with CVD risk factors in Cau-
casian men and women without a history of CVD?
Methods
Definitions
Cardiovascular disease risk factors
We chose to focus on the CVD risk factors reported by the
ATP III definition [2]. High blood pressure (systolic blood
pressure >130 mmHg and/or diastolic blood pressure
>85 mmHg), low HDL-C (men <1.03 mmol/l; women
<1.30 mmol/l), high triglycerides (>1.70 mmol/l) and fast-
ing glucose (>6.1 mmol/l).
Anthropometric adiposity measures
We only considered simple measures that give an indication
of fat mass or body fat distribution. The most frequently
used measures were BMI, waist circumference, waist-to-hip
ratio, waist-to-height ratio and BF% calculated from skin
folds or bio-electrical impedance. Studies that describe an-
thropometric methods not commonly used in practice were
excluded. Examples of such methods are magnetic reso-
nance imaging or dual-emission X-ray absorptiometry
techniques.
Body mass index
General obesity is widely measured with the BMI. BMI is
calculated as weight in kg divided by squared height in
meters (kg/m
2). There is consensus about the used cut-off
points in a Caucasian population, which are described in
Table 1 [11, 13].
Waist circumference
Waist circumference is reported as the better measurement
for central obesity and therefore a good predictor of abdom-
inal visceral fat [6–9]. There is general consensus about
waist circumference cut-off points for increased CVD risk
in a Caucasian population: >102 cm for men and >88 cm
for women [2, 11, 13]. These cut-off points correspond to
the BMI values for “obese class I” where >90 cm for men
and >80 cm for women correspond to BMI values for
“overweight/pre-obese” [14].
Waist-to-hip ratio
This ratio was developed because waist and hip circum-
ferences measure different aspects of body composition
and fat distribution and have independent and often opposite
effects on CVD risk factors. A narrow waist and large hips
Table 1 BMI cut-off
points Classification BMI (kg/m
2)
Underweight <18.5
Normal weight 18.5–24.99
Overweight ≥25.00
- Pre-obese 25.00–29.99
- Obese I 30.00–34.99
- Obese II 35.00–39.99
- Obese III ≥40.00
Neth Heart J (2012) 20:208–218 209may both protect against cardiovascular disease [15]. Cut-
off points that indicate increased CVD risk for waist-to-hip
ratio have been calculated by Dobbelsteyn et al. and are 0.9
and 0.8 for men and women, respectively [14].
Waist-to-height ratio
This simple measure adds the factor height to the waist
circumference. Like the other anthropometric adiposity
measurements, ethnic differences require different cut-
off points. For Caucasian populations, however, we did
not find any well-established cut-off points for waist-to-
height ratio.
Body fat percentage
Two methods of anthropometric BF% measurement tech-
niques have been developed and validated. First is the
skin fold method where BF% can be calculated from
skin fold measures at four sites on the body [16]. Second
bio-electrical impedance can be used to estimate BF%.
With this method a small alternating current is applied to
the body. Different body tissues have different resistivity
and therefore a calculation can be made with this method
to estimate the BF% [17]. A BF% of >25% or >35% for
m e na n dw o m e n ,r e s p e c t i v e l y ,i sc o r r e l a t e dt oaB M Io f
30 and chosen as cut-off-points for Caucasian people
[12].
Caucasians
Defining who is Caucasian or not is problematic. Strictly,
they might be the people who lived in the Caucasus, but in
common use a Caucasian is referred to as a European or
someone with European ancestry. This is somewhat hard to
control when examining a large population, for example, in
the US or Australia. In scientific literature Caucasians are
also sometimes called whites. In this review we chose to
include only Caucasians because of reported differences in
anthropometric adiposity measures and their associations
with CVD risk factors in different ethnicities. In selecting
articles for this review we chose to exclude mainly the
studies that comprised populations of which we knew they
differ from Caucasian populations. For example Asians [2,
12, 18, 19], Africans [2, 12, 20], Aboriginal Australians [21]
and Hispanics/Latin Americans [2, 22] have been studied
and reported to differ from standards based on Caucasian
populations.
We included studies that describe European, American,
Canadian and Australian populations. No studies were
found that reported big differences between these popula-
tions. This does not mean, however, that differences do not
exist.
Search strategy
A search strategy was created by the first author (SvD) with
the support of a medical librarian and critically reviewed
and approved by the direct supervisor (HW). After approval
published articles in the following databases were searched:
PubMed (1966–Nov. 2009), CINAHL (1966–Nov. 2009),
EMBASE (1947–Nov. 2009) and Cochrane Controlled
Trials Register (CENTRAL) (The Cochrane Library 2009
issue 11). The search strategy did not have any limitations
on ethnicity. Five potentially eligible articles were manu-
ally searched before applying the search strategy. When
conducting the search strategy these five articles had to be
found to ensure that the strategy covered all our criteria.
This method fine-tuned the strategy and created a small
certainty that we did not miss important articles.
Eligibility criteria
Types of participants
Only studies that described results on Caucasian adults
without a history of CVD were included.
Types of studies
All types of research designs were included. Only studies
for which a full-text article in the English or Dutch language
was available were considered for inclusion.
Types of outcome measures
Included were studies that reported correlations between
different anthropometric adiposity measures and CVD risk
factors. At least two anthropometric measures had to be
compared with at least three of four CVD risk factors.
Secondary outcomes were total cholesterol and low-
density lipoprotein cholesterol data. The possibilities are
displayed in Fig. 1. The study had to report correlation
coefficients between anthropometric adiposity measures
and CVD risk factors. If these correlations were not
reported, but could be calculated from given data, the study
was considered for inclusion. Correlation coefficients had to
be reported for men and women separately and in the case of
multi-ethnic studies the data had to be reported for each
ethnic group, in order to extract Caucasian data. When this
was not the case this study was excluded.
Study selection
One reviewer (SvD) made a first selection of articles based
on title only. Only study titles obviously not involving any
study criteria for this review were excluded.
210 Neth Heart J (2012) 20:208–218After exclusion based on title alone two independent
reviewers (SvD and EP) selected articles based on the ab-
stract. After selection, the reviewers independently applied
the inclusion criteria on the full text articles and decided on
inclusion or not. Disagreement with including articles was
solved with discussion and a third reviewer was consulted if
disagreement still persisted.
Study quality assessment
We chose not to assess methodological quality of the
included studies. There is no consensus on which checklist
to use and most checklists involve quality assessment of
clinical trials [23]. Our research question can not be an-
swered with results from clinical trials, so most available
checklists will not be useful to us. Also we found no
recommendations on how to incorporate a quality score
in a meta-analysis.
Data extraction
In case of good but insufficient data presented in the
studies, authors were mailed to gain more specific results
that could be used in our meta-analysis. Data from includ-
ed articles were summarised in a table. Two independent
reviewers selected data on relevant characteristics to mini-
mise potential bias or mistakes in the data extraction process.
Characteristics described in the table were: first author and
publication year, study name (acronym), baseline year(s),
sample size, population age, population gender, population
ethnicity, anthropometric adiposity measurements used,
CVD risk factors assessed, association parameter used, sta-
tistical adjustments, association parameter results.
Data interpretation
Pearson correlations were interpreted according to magni-
tudes as proposed by Cohen et al. [24]. Very small: 0.0–0.1,
small: 0.1–0.3, moderate: 0.3–0.5, large: 0.5–0.7, very
large: 0.7–0.9 and almost perfect: 0.9–1.0.
Statistical analyses
We used a fixed-effects model for computing mean correla-
tions. First, all correlations were converted to the Fisher’s
z-scale and weighted by the number of subjects to calculate
the mean Fisher’s Z as described by Field et al. in Eq. 2 [25].
These were inverted in the end to display an actual r-value.
With use of standard deviations of these r-values and the
number of studies performed, we calculated the 95% confi-
dence interval (95% CI) for each of the mean correlations and
plotted the results for each CVD risk factor ina forestplot. By
examining the 95% CI we determined the statistical signifi-
cance between the correlations for each of the anthropometric
adiposity measures. When 95% CIs did not overlap we as-
sumed a significant difference atthe p00.05level.When95%
CIs overlapped, a 95% CI was calculated for the difference
between the means and determined whether this 95% CI
contained zero. If it did contain zero the difference was not
significant and if it did not contain zero the difference was
deemed significant [26]. All statistical analyses were per-
formed in Microsoft Office Excel 2008 for Mac.
Results
Study selection
The search strategy yielded a total of 991 hits. Ninety-eight
articles initially appeared to meet inclusion criteria, 78 of
which were eventually excluded, resulting in a total of 20
definite inclusions. A flowchart displaying exact details on
the definite inclusion is presented in Fig. 2. Most exclusions
in the full-text selection were made because complete data
were not available, other statistics than Pearson or Spearman
correlations were used, a separate analysis was not per-
formed for ethnic groups or gender and there were multiple
publications describing the same study population.
Study characteristics
The oldest article included was published in the year 1986
and the most recent study was published in 2009. Most
Fig. 1 Graphical display of all
outcome measures
Neth Heart J (2012) 20:208–218 211studies used cross-sectional designs and tested persons who
voluntarily participated in preventive medical examinations.
All studies together examined a total of 45,757 subjects;
21,618 males and 24,139 females. Nine studies, comprising
86% of all subjects together, included subjects roughly
between 18 and 90 years of age. The other studies included
only subjects within a smaller age spectrum.
Distribution of subjects in the four major regions
was quite identical with 12,037 subjects from the USA
(4 studies), 9820 subjects from Canada (3 studies), 11,247
subjects from Australia (1 study) and 12,653 subjects from
Europe (12 studies).
BMI,waist circumference (WC), waist-to-hip ratio (WHR),
waist-to-height ratio (WHtR) and BF% were described in 19,
16, 17, 6 and 1 study respectively. BF%, calculated from four
skin folds, was only reported by Contaldo et al. [27] and
therefore there was no manner to quantitatively analyse this
data. Results of this study were not included into our analysis.
Twelve studies described all four primary CVD outcome
measures [15, 28–37], eight described only three [9, 38–44].
The study by Seidell et al. [41] described five different
European populations and reported data for each population
separately. These data were therefore analysed as five dif-
ferent study populations.
All studies used a Pearson correlation coefficient to de-
termine associations except for the study by Ohrvall et al.
[35] who used a Spearman rank correlation coefficient.
Studies varied in use of adjustments in calculation of the
correlation coefficients but when we studied the data we
found no obvious differences between adjusted and unad-
justed data. More detailed information about the study char-
acteristics are displayed in Table 2.
Study results for men
All data on men are displayed in Fig. 3. Moderate correla-
tions were found for all anthropometric adiposity measures
with triglycerides (TG). Also, moderate correlations were
found for WC with systolic blood pressure (SBP), and for
BMI and WC with diastolic blood pressure (DBP). All other
correlations were small. We found the strongest correlations
between WC and SBP, DBP, total cholesterol (TC), trigly-
cerides (TG) and fasting glucose (FG). These correlations
were significantly higher than those of other anthropometric
adiposity measures for SBP and DBP. For HDL we found
WC to correlate almost as well as BMI. For LDL we found
WHR to have the best correlation, however not significant.
We found WC to correlate significantly better than BMI
with SBP, DBP, LDL, TG and FG. The weakest correlate
to all the CVD risk factors was WHtR, significantly differing
from other anthropometric adiposity measures for SBP, DBP,
HDL, TC and FG.
Study results for women
All data on women are displayed in Fig. 4.V e r ys m a l l
correlations were found for WHtR with LDL and TC. Mod-
erate correlations were found for WC with SBP, WC and
BMI with DBP, WC with HDL and BMI, WC and WHR
with TG. All other correlations were small. For all CVD risk
factors WC was the strongest correlate. This correlation was
found to be statistically significant (p<0.05) for SBP only.
For LDL, TC, TG and FG, WHR approached the WC
correlation, making WC not the overall significantly better
correlate. WC correlates significantly better with all CVD
risk factors than BMI (p<0.05), except for DBP. We found
WHtR to be the weakest correlate of all anthropometric
adiposity measures.
Discussion
The aim of our study was to investigate which anthropo-
metric adiposity measure had the strongest association with
cardiovascular disease risk factors in Caucasian men and
women without a history of cardiovascular disease. We found
WC to have the strongest associations among almost all CVD
risk factors for both men and women, although not always
Fig. 2 Article flow chart
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Neth Heart J (2012) 20:208–218 213Fig. 3 Mean Pearson correlations and their 95% confidence intervals
plotted for men. ∗WC correlates significantly better than BMI, WHR
and WHtR (P<0.05). **WHR correlates significantly better than BMI
and WHtR (P<0.05). †WC correlates significantly better than BMI
and WHtR (P<0.05). ‡WC correlates significantly better than WHR
and WHtR (P<0.05). §BMI correlates significantly better than WHR
and WHtR (P<0.05). SD standard deviation; Ns number of subjects;
Np number of populations
214 Neth Heart J (2012) 20:208–218Fig. 4 Mean Pearson correlations and their 95% confidence intervals
plotted. ∗WC correlates significantly better than BMI, WHR and
WHtR (P<0.05). ∗∗ WC correlates significantly better than BMI and
WHR (P<0.05). ***WHR correlates significantly better than BMI and
WHtR (P<0.05). †WC correlates significantly better than BMI and
WHtR (P<0.05). ‡WC correlates significantly better than WHR and
WHtR (P<0.05). §BMI correlates significantly better than WHR and
WHtR (P<0.05). SD standard deviation; Ns number of subjects; Np
number of populations
Neth Heart J (2012) 20:208–218 215significantly. Especially when BMI was compared with WC
the latter holds significantly better correlations to CVD risk
factors except for DBP in women and HDL and TC in men.
Comparing BMI and WHR resulted in only small and mostly
non-significant differences except for TC and TG in women
and LDL in men in favour of WHR. The weakest correlations
were found for WHtR.
Our study selection procedure yielded only one study that
used a measure of BF% [27]. This study reported rather
moderate and large correlations between BF% and CVD risk
factors (0.54, 0.4, 0.37, 0.37 and 0.36 with SBP, DBP, TC,
TG and FG respectively for women, 0.38, 0.46, 0.37, 0.42
and 0.31 with SBP, DBP, TC, TG and FG respectively for
men). This study compared BF% with BMI and also found
moderate and large correlations between BMI and CVD risk
factors. Based on these data, BF% could be a competitor for
the strongest correlations with CVD risk factors; however,
more studies should be done before any conclusions can be
drawn.
Janssen et al. [45] analysed the data from the NHANES
III database to determine whether the prevalence of CVD
risk factors is greater in individuals with high WC values
compared with individuals with normal WC values within
the same BMI category. Individuals with high WC values
were reported to have significantly greater prevalence of
CVD risk factors even within the same BMI category, thus
underscoring the importance of WC. When evaluating the
clustering of CVD risk factors in the metabolic syndrome,
Schneider et al. [46] and Dervaux et al. [47] concluded that
WC had a stronger association with the metabolic syndrome
than BMI.
One should also consider some practical issues with
anthropometric adiposity measures. The general idea behind
using anthropometric adiposity measures is to predict a
certain risk and to measure change over time when compar-
ing interventions. The ability to detect change in the differ-
ent anthropometric adiposity measures can play an
important role here. Velthuis et al. [48] conducted a rando-
mised controlled trial and investigated the effect of a 12-
month moderate-to-vigorous exercise program combining
aerobic and muscle strength training on body composition
among 189 sedentary, postmenopausal women. Their data
showed that the exercise program was able to reduce fat
mass, increase lean body mass and reduce WC, although
weight and BMI were not affected. Kwak et al. [49] found
similar results in a randomised controlled trial with 553
male and female subjects. This further supports the use of
alternative anthropometric adiposity measures next to BMI,
such as WC, as a more responsive outcome.
This meta-analysis holds a few study limitations. Hetero-
geneity of study populations remains a subject of discussion.
Whether Europeans differ amongst each other and can be
compared with for example Canadians is not known. We
found nostudies describingobjective differencesamong these
populations and in order to reach sufficient power in our
analysis we made the choice to compare all these populations.
Although the subject inclusion criteria for all studies were
almost the same it remains difficult to control for other known
CVD risk factors, for example smoking status, physical activ-
ity or fitness levels, social status and nutrition.
Studies might have been missed by our search method
even though we tried to validate the strategy. Studies de-
scribing associations between only one anthropometric adi-
posity measure and three or less CVD risk factors were not
included although maybe holding valuable data for our
analysis. Furthermore, a few large studies found with our
strategy did not report correlation coefficients and were
therefore excluded after attempting to get the data from
authors by mail and failing. Calculating the needed correla-
tion coefficients would be easily done and could alter or
strengthen the results of our study.
A comment should also be made about the fact that we
studied CVD risk factors and not cardiovascular diseases or
mortality rates. As we found correlations between anthro-
pometric adiposity measures and CVD risk factors were
generally small to moderate, it can be expected that even
weaker correlations with actual cardiovascular disease will
be found. This was addressed in a recent large study per-
formed by The Emerging Risk Factors Collaboration [50].
They concluded that BMI, WC, and WHR, whether
assessed singly or in combination, did not importantly im-
prove cardiovascular disease risk prediction in people in
developed countries when additional information is avail-
able for systolic blood pressure, history of diabetes, and
lipids [50].
Although relationships between anthropometric adiposity
measures and CVD risk factors have been explored thor-
oughly in many studies around the world this is the first
study to our knowledge to combine these results quantita-
tively in a meta-analysis. Waist circumference has been a
widely used measure for adiposity for some time now and
we believe the evidence supporting its use has been
strengthened with the current study. The results of our study
can, however, only be generalised to people of Caucasian
descent.
Recommendations
Although overall correlations between CVD risk factors and
anthropometric adiposity measures were small, they do ap-
pear to be significant. Given the extent of the cardiovascular
disease problem in the industrialised world, it is important
clinicians should use a measure that most accurately reflects
CVDrisk.Fromthisstudyweconcludedthatthemeasurement
of WC was more related to CVD risk factors in men and
216 Neth Heart J (2012) 20:208–218women than BMI. We therefore recommend the use of WC in
the clinic and in research studies.
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